Improved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect

American Journal of Therapeutics

Volumn 7, Issue 1, 2000, Pages 17-22

  Basu, Sumit K ^a   Kinsey, Christopher D ^a   Miller, Alan J ^b   Lahiri, Avijit ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b Napp Laboratories   (United Kingdom)

Author keywords

Diltiazem CR; Nifedipine SR; Stable angina

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NIFEDIPINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CHEMICAL PHENOMENA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANGINA PECTORIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DEPRESSION, CHEMICAL; DILTIAZEM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 0033754962     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200007010-00004     Document Type: Article

References (19)

1. Khurmi NS, Raftery EB: A comparison of nine calcium antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris. Eur J Clin Pharmacol 1987;32: 539-548.
2. Cannon RO, Watson RM, Rosing DR, Epstein SE: Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol 1985; 56:242-246.
3. Opie LH: Calcium channel antagonists: Part II. use and comparative properties of the three prototypical calcium antagonists in ischaemic heart disease, including recommendations based on an analysis of 41 trials. Cardiovasc Drugs Ther 1988;1:461-491.
4. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
5. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
6. Opie LH, Messerli FH: Nifedipine and mortality: grave defects in the dossier. Circulation 1995;92:1068-1073.
7. Stone PH, Gibson RS, Glasser SP, et al, and the ASIS Study Group: Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina: differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. Circulation 1990;82:1962-1972.
8. Lahiri A, Rodrigues EA, Carboni GP, Raftery EB: Effects of chronic treatment with calcium antagonists on left ventricular diastolic function in stable angina and heart failure. Circulation 1990;81(suppl III):130-138.
9. Fleckenstein A: Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the production or prevention of myocardial lesions. In: Calcium and the Heart. Proceedings of the Meeting of the European Section of the International Study Group for Research in Cardiac Metabolism. (Eds. Harris P, Opie L), Academic Press, New York, 1970, pp 135-188.
10. Nayler WG, Grau A, Slade A: A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res 1976; 10:650-662.
11. Nagao T, Matlib MA, Franklin D, et al: Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. J Mol Cell Cardiol 1980;12:29-43.
12. Myers MG: Dihydropyridine calcium antagonists and the trough:peak ratio: focus on adverse effects. J Hypertens 1994;12(suppl 8):S73-S77.
13. Jariwalla AG, Anderson EG: Side effects of drugs: production of ischemic pain by nifedipine. BMJ 1978;1:1181.
14. Yokoyama M, Koizumi T, Fujitani K, et al: Adverse response to nifedipine in unstable angina pectoris. Chest 1982;81:646.
15. Schanzenbacker P, Deeg P, Liebau G, Kochsiek K: Paradoxical angina after nifedipine: angiographic documentation. Am J Cardiol 1984;53:345.
16. Boden WE, Korr KS, Bough EW: Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. JAMA 1985;253:1131.
17. Elkayam U, Amin J, Mehra A, et al: A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1961.
18. Goldstein RD, Boccuzzi SJ, Cruess D, Nattel S, the Adverse Experience Committee and the multicenter Diltiazem Postinfarction Research Group: Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
19. Pouleur H: Calcium antagonists or β-blockers in chronic ischaemic left ventricular dysfunction? Eur Heart J 1993; 14(suppl F):26-28.